Grants and Contributions:
Title:
Biomanufacturing Centre Project.
Agreement Number:
815823
Agreement Value:
$3,522,703.00
Agreement Date:
Jun 1, 2020 - Mar 26, 2025
Description:
This project aimed to establish Canada’s first end-to-end manufacturing of genetic medicines for the production of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The biomanufacturing project was to allow PNU to expand their ability to produce ribonucleic acid vaccines and future genetic medicines in Canada.
Location:
Vancouver, British Columbia, CA V6P6T7
Reference Number:
033-2020-2021-Q4-815823
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
851285114
Recipient Type:
For-profit organization
Additional Information:
The amendment has been completed to terminate the contribution agreement by mutual consent.
Amendment Date
Mar 26, 2024
Recipient's Operating Name:
Precision NanoSystems ULC
Recipient's Legal Name:
Precision NanoSystems ULC
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
541710
Amendments: